NO20061424L - Fremgangsmote for fremstillingen av THIP - Google Patents

Fremgangsmote for fremstillingen av THIP

Info

Publication number
NO20061424L
NO20061424L NO20061424A NO20061424A NO20061424L NO 20061424 L NO20061424 L NO 20061424L NO 20061424 A NO20061424 A NO 20061424A NO 20061424 A NO20061424 A NO 20061424A NO 20061424 L NO20061424 L NO 20061424L
Authority
NO
Norway
Prior art keywords
thip
preparation
alkyl
acid
procedure
Prior art date
Application number
NO20061424A
Other languages
English (en)
Norwegian (no)
Inventor
Robert Dancer
Hans Petersen
Michael Bech Somrner
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=58707236&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20061424(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20061424L publication Critical patent/NO20061424L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20061424A 2003-09-05 2006-03-29 Fremgangsmote for fremstillingen av THIP NO20061424L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50042203P 2003-09-05 2003-09-05
DKPA200301277 2003-09-05
PCT/DK2004/000579 WO2005023820A1 (en) 2003-09-05 2004-09-01 Method for the manufacture of thip

Publications (1)

Publication Number Publication Date
NO20061424L true NO20061424L (no) 2006-03-29

Family

ID=58707236

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061424A NO20061424L (no) 2003-09-05 2006-03-29 Fremgangsmote for fremstillingen av THIP

Country Status (20)

Country Link
US (1) US7371863B2 (sr)
EP (1) EP1664060A1 (sr)
JP (1) JP4745233B2 (sr)
KR (1) KR20060069482A (sr)
CN (2) CN101497619A (sr)
AR (1) AR045540A1 (sr)
AU (1) AU2004270323B2 (sr)
BR (1) BRPI0413741A (sr)
CA (1) CA2537840C (sr)
EA (1) EA200600542A1 (sr)
IL (1) IL174070A (sr)
IS (1) IS8333A (sr)
ME (1) MEP1708A (sr)
MX (1) MXPA06002434A (sr)
NO (1) NO20061424L (sr)
NZ (1) NZ545178A (sr)
RS (1) RS20060157A (sr)
UA (1) UA91496C2 (sr)
WO (1) WO2005023820A1 (sr)
ZA (1) ZA200602178B (sr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0402118D0 (en) 2004-01-30 2004-03-03 Merck Sharp & Dohme Polymorphic forms of a GABAA agonist
AU2005229493A1 (en) * 2004-04-02 2005-10-13 H. Lundbeck A/S Treatment of impaired respiratory function with gaboxadol
CN104974175A (zh) * 2014-04-11 2015-10-14 天津药物研究院 一种氨甲基羟异恶唑类似物的制备方法
DK3274331T3 (da) 2015-03-24 2020-03-23 H Lundbeck As Fremstilling af 4,5,6,7-tetrahydroisozaxolo[5,4-c]pyridin-3-ol
GB2594616A (en) 2018-11-21 2021-11-03 Certego Therapeutics Inc Gaboxadol for reducing risk of suicide and rapid relief of depression
CN111320577B (zh) * 2018-12-13 2023-06-23 广东东阳光药业有限公司 一种吡啶酰胺的制备方法及其应用
IL298334A (en) 2020-05-20 2023-01-01 Certego Therapeutics Inc Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK270378A (da) 1977-06-20 1978-12-21 Krogsgaard Larsen P Isoxazolderivater
GB2088370B (en) * 1980-11-27 1984-08-01 Kefalas As Tetrahydroisoxazolopyridine compounds
DE3145473A1 (de) * 1980-11-27 1982-08-26 Kefalas A/S, Koebenhavn-Valby 2-substituierte 4,5,6,7-tetrahydroisoxazolo (5,4-c) pyridin-3-on-verbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4353910A (en) * 1981-11-27 1982-10-12 Kefalas A/S Derivatives of 4,5,6,7-tetrahydroisoxazolo [5,4-c] pyridine-3-one, pharmaceutical compositions and methods of treatment
DE19525598C2 (de) 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel

Also Published As

Publication number Publication date
US7371863B2 (en) 2008-05-13
EA200600542A1 (ru) 2006-08-25
JP2007504179A (ja) 2007-03-01
HK1096398A1 (en) 2007-06-01
EP1664060A1 (en) 2006-06-07
IL174070A0 (en) 2006-08-01
CN1845928A (zh) 2006-10-11
AR045540A1 (es) 2005-11-02
IL174070A (en) 2011-03-31
CA2537840C (en) 2011-10-25
AU2004270323B2 (en) 2010-01-07
NZ545178A (en) 2009-11-27
CN101497619A (zh) 2009-08-05
US20070112198A1 (en) 2007-05-17
CA2537840A1 (en) 2005-03-17
BRPI0413741A (pt) 2006-10-24
KR20060069482A (ko) 2006-06-21
CN100482668C (zh) 2009-04-29
RS20060157A (sr) 2008-06-05
MEP1708A (xx) 2010-02-10
ZA200602178B (en) 2007-07-25
IS8333A (is) 2006-02-28
JP4745233B2 (ja) 2011-08-10
UA91496C2 (en) 2010-08-10
WO2005023820A1 (en) 2005-03-17
AU2004270323A1 (en) 2005-03-17
MXPA06002434A (es) 2006-06-20

Similar Documents

Publication Publication Date Title
NO20065830L (no) Substituerte 2-kinolyloksazoler som er anvendbare som PDE4-inhibitorer.
NO902214L (no) Fremgangsmaate for fremstilling av n-(aryloksyalkyl)-heteroarylpiperidiner og -heteroarylpiperaziner, deres fremstilling og anvendelse.
EA200501477A1 (ru) Производные пиперидинил- и пиперазинилалкилкарбаматов, способы их получения и применение их в терапии
PE20051039A1 (es) [1,8] naftiridin-2-onas y compuestos relacionados
CA2324418A1 (en) Novel opiate compounds, methods of making and methods of use
PE20050480A1 (es) Acido [2-(8,9-dioxo-2,6-diazabiciclo [5.2.0] non-1(7)-en-2-il)alquil]fosfonico y derivados
HRP20070430T3 (en) (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
PE20091887A1 (es) Fenoxibenzamidas sustituidas
NO20081056L (no) Nye, heterosykliske NF-kB-inhibitorer
NO20061424L (no) Fremgangsmote for fremstillingen av THIP
NO20082226L (no) 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav
DE602006008962D1 (de) Verfahren zur herstellung von valsartan
GB0326964D0 (en) Chemical compounds
NO20070972L (no) Benzyloksyderivater som MAOB-inhibitorer
NO20073213L (no) Fremgangsmate for fremstilling av tiofenglykosidderivater
BG106846A (en) Novel heteroaryl derivatives, their preparation and use
FI20030026A0 (fi) Menetelmä substituoitujen imidatsolijohdannaisten valmistamiseksi ja menetelmässä käytettäviä välituotteita
NO20002315D0 (no) Nye 1-aza-2-alkyl-6-aryl-cykloalkanforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
DE69107561D1 (de) Verfahren zur Herstellung von 4-Methylsulfonylbenzoesäurederivate und Zwischenprodukte.
NO20070610L (no) Fremgangsmate for fremstilling av synteseintermediater anvendelige ved fremstilling av pyrazolforbindelser.
SI2298754T1 (sl) Priprava derivatov taksana
BR0105801B1 (pt) processo para produÇço de derivado alquilamina substituÍdo.
DE69815906D1 (de) Verfahren zur Herstellung von Chloroacetylaminothiazoleaceticsäure Derivate
NO20055755L (no) Nytt intermediat for fremstillingen av terapeutisk aktive imidazopyridiner
TH76525A (th) อนุพันธ์เบนซิลออกซีเป็นสารยับยั้ง maob

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

FC2A Withdrawal, rejection or dismissal of laid open patent application